secwatch / observer
8-K filed May 12, 2023, 7:59 PM ET ticker PULM CIK 0001574235
earnings confidence high sentiment neutral materiality 0.60

Pulmatrix reports Q1 net loss $4.45M; cash runway extended to Q4 2024

Pulmatrix, Inc.

2024-Q1 EPS reported -$1.22 revenue$1,499,000
item 2.02item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pulmatrix, Inc. reported the three months ended March 31, 2023 results: revenue $1.5 million.

Period
the three months ended March 31, 2023
Revenue
$1.5 million
Result
reported results
Exact text from the filing
Revenues increased $0.3 million to $1.5 million for the three months ended March 31, 2023 compared to $1.2 million for the three months ended March 31, 2022.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pulmatrix, Inc. reported financial results for the first fiscal quarter ended March 31, 2023.

Period
the first fiscal quarter ended March 31, 2023
Result
reported results
Exact text from the filing
On May 12, 2023, Pulmatrix, Inc. (the “Company”) issued a press release announcing its financial results for the first fiscal quarter ended March 31, 2023 and provided a corporate update. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
View on SEC.gov

Browse all earnings releases →

Pulmatrix, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-016511
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.